Literature DB >> 24792985

Assessment of reproducibility--automated and digital caliper ECG measurement in the Framingham Heart Study.

Gordon M Burke1, Na Wang2, Sue Blease3, Daniel Levy4, Jared W Magnani5.   

Abstract

BACKGROUND: Digitized electrocardiography permits the rapid, automated quantification of electrocardiograms (ECGs) for analysis. Community- and population-based studies have increasingly integrated such data. Assessing the reproducibility of automated ECG measures with manual measures is a critical step in preparation for using automated measures for research purposes. We recently established an ECG repository of digitally recorded ECGs for the Framingham Heart Study and we sought to assess the reproducibility of automated and manual measures.
METHODS: We selected 185 digitally recorded ECGs from routine visits of Framingham Heart Study participants spanning from 1986 to 2012. We selected the following ECG measures for their relevance to clinical and epidemiologic research: P wave duration, P wave amplitude, and PR interval in lead II; QRS duration and R wave amplitude in lead V6; and QT interval in lead V5. We obtained automated values for each waveform, and used a digital caliper for manual measurements. Digital caliper measurements were repeated in a subset (n=81) of the samples for intrarater assessment.
RESULTS: We calculated the intraclass correlation coefficient (ICC) values for the interrater and intrarater assessments. P wave duration had the lowest interrater ICC (r=0.46) and lowest intrarater ICC (r=0.57). R wave amplitude had the highest interrater and intrarater ICC (r=0.98) indicating excellent reproducibility. The remaining measures had interrater and intrarater ICCs of r≥0.81.
CONCLUSIONS: The interrater reproducibility findings for P wave amplitude, PR interval, QT interval, QRS duration, and R wave amplitude were excellent. In contrast, the reproducibility of P wave duration was more modest. These findings indicate high reproducibility of most automated and manual ECG measurements.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Electrocardiogram; P waves; QRS complex; QT interval; Reproducibility

Mesh:

Year:  2014        PMID: 24792985      PMCID: PMC4010803          DOI: 10.1016/j.jelectrocard.2014.01.004

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  6 in total

1.  More light on QT interval measurement.

Authors:  L Toivonen
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.

Authors:  A Mosterd; R B D'Agostino; H Silbershatz; P A Sytkowski; W B Kannel; D E Grobbee; D Levy
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

3.  P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).

Authors:  Jared W Magnani; Michael J Mazzini; Lisa M Sullivan; MaryAnn Williamson; Patrick T Ellinor; Emelia J Benjamin
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-01       Impact factor: 1.468

4.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

5.  Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.

Authors:  D Levy; M Salomon; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

6.  Development and application of a longitudinal electrocardiogram repository: the Framingham Heart Study.

Authors:  Jared W Magnani; Christopher Newton-Cheh; Christopher J O'Donnell; Daniel Levy
Journal:  J Electrocardiol       Date:  2012-07-24       Impact factor: 1.438

  6 in total
  6 in total

1.  Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of Acetazolamide.

Authors:  Tsogyal Daniela Latshang; Barbara Kaufmann; Yvonne Nussbaumer-Ochsner; Silvia Ulrich; Michael Furian; Malcolm Kohler; Robert Thurnheer; Ardan Muammer Saguner; Firat Duru; Konrad Ernst Bloch
Journal:  Sleep       Date:  2016-09-01       Impact factor: 5.849

2.  Reproducibility of global electrical heterogeneity measurements on 12-lead ECG: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Kazi T Haq; Katherine J Lutz; Kyle K Peters; Natalie E Craig; Evan Mitchell; Anish K Desai; Nathan W L Stencel; Elsayed Z Soliman; João A C Lima; Larisa G Tereshchenko
Journal:  J Electrocardiol       Date:  2021-10-02       Impact factor: 1.438

3.  Evaluation of the 2021 European Society of Cardiology guidelines in pre-existing right bundle branch block patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve.

Authors:  Toshiaki Isogai; Iryna Dykun; Ankit Agrawal; Shashank Shekhar; Khaldoun G Tarakji; Oussama M Wazni; Ankur Kalra; Amar Krishnaswamy; Grant W Reed; Samir R Kapadia; Rishi Puri
Journal:  Eur Heart J Open       Date:  2022-03-11

Review 4.  P Wave Parameters and Indices: A Critical Appraisal of Clinical Utility, Challenges, and Future Research-A Consensus Document Endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology.

Authors:  Lin Yee Chen; Antonio Luiz Pinho Ribeiro; Pyotr G Platonov; Iwona Cygankiewicz; Elsayed Z Soliman; Bulent Gorenek; Takanori Ikeda; Vassilios P Vassilikos; Jonathan S Steinberg; Niraj Varma; Antoni Bayés-de-Luna; Adrian Baranchuk
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-03-25

5.  Diagnostic accuracy of computer aided electrocardiogram analysis in dogs.

Authors:  A H Estrada; A Spake; M E Kleman; D Leeder; D Blischok-Lapekas; M Margiocco; J Gentile-Solomon; N Piscitelli; D Szlosek
Journal:  J Small Anim Pract       Date:  2020-12-01       Impact factor: 1.522

6.  Confirmation of the Cardiac Safety of PGF Receptor Antagonist OBE022 in a First-in-Human Study in Healthy Subjects, Using Intensive ECG Assessments.

Authors:  Jörg Täubel; Ulrike Lorch; Simon Coates; Sara Fernandes; Paul Foley; Georg Ferber; Jean-Pierre Gotteland; Oliver Pohl
Journal:  Clin Pharmacol Drug Dev       Date:  2018-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.